Amylin + Triple Agonist Blend
Pre-mixed blend of cagrilintide 5mg (amylin analog) and retatrutide 5mg (GLP-1/GIP/glucagon triple agonist) in one vial. Studied in metabolic and weight-management models.
This blend pairs two research peptides in a single vial: cagrilintide, a long-acting amylin analog, and retatrutide, a GLP-1/GIP/glucagon triple receptor agonist. Each 10mg vial holds 5mg of each. Amylin signaling and incretin signaling act through separate pathways, which is why amylin analogs are commonly studied alongside incretin agonists in metabolic research.
Store lyophilized at -20°C. Reconstituted: refrigerate 2–8°C, use within 4–6 weeks.